Bota Biosciences
PrivateLast Round
Series B
Jul 29, 2021
Total Funding Raised
$115M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bota Biosciences operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in July 2021.
Bota Biosciences is a biotechnology company that develops an industrial synthetic biology platform for the sustainable bio-manufacturing of high-performance ingredients and compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bota Biosciences Comparables
Compare Bota Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tidetron Bioworks | 79% | |
| DataHow AG | 78% | |
| SynBioLab | 77% |
For institutional investors. Book with your work email.
Bota Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2021 | ||||
| Strategic | Mar 16, 2021 | ||||
| Series A | Sep 25, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bota Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B, Series A |
| Nest.Bio | Seed |
| 5Y Capital | Series B |
| MPC | Series B, Series A |
| Source Code Capital | Series B |
| Sherpa Healthcare Partners | Series B, Series A |
| BASF Venture Capital | Strategic |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 76% MoM.
- Apr 18, 2026
Monthly visitors grew 105% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
Bota Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bota Biosciences's valuation, stock price, and market status.
Is Bota Biosciences a public or private company?
Bota Biosciences is a private company.
What is the current stock price of Bota Biosciences?
Bota Biosciences is a private company, so its shares have no public market price. Caplight tracks Bota Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bota Biosciences worth (valuation)?
Valuation information for Bota Biosciences is not publicly available.
Can I buy Bota Biosciences stock?
Bota Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bota Biosciences's last funding round?
Bota Biosciences's most recent funding round was Series B on July 29, 2021.
Who are the main investors in Bota Biosciences?
Key investors in Bota Biosciences include Matrix, MPC, BASF Venture Capital, HongShan Capital Group (HSG).
Will Bota Biosciences IPO soon?
No public IPO plans have been announced for Bota Biosciences.
How can I track Bota Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Bota Biosciences's shares on secondary markets.